A resorbable, inorganic material that has the ability to elicit bone remodeling comparable to biologic materials looks promising for orthopedic extremity surgery. Because it is synthetic, Vitrium from Bio2 Technologies Inc. does not carry the risk of biologic materials, and is much less expensive, according to president and CEO Paul Nichols.
Vitrium is a three-dimensional porous scaffold that can also withstand physiologic loads
Bio2 is initially targeting the one million foot and ankle surgeries performed annually in the US, driving a $500m yearly opportunity